Overview:
Probiomedica, a start-up founded in 2015, combines engineering, biology, photonics and robotics and aims to develop innovative devices for applications in the service of health and the person. Probiomedica with its experts is dedicated to the study of technological innovations to be used to improve its products and create new ones. The first product of the company under development is CapsuLight, an ingestible led capsule for the treatment of infection with Helicobacter pylori.
The capsule, as small as an antibiotic pill, uses simple LEDs and a normal battery, emitting light of specific wavelengths to cause the elimination of Helicobacter, without the side effects related to antibiotic-resistance. The disposable capsule is based on technologies similar to those of diagnostic endoscopic capsules, which have been commercially available for 15 years.
